Biopsy or Follow-up: AI Improves the Clinical Strategy of US BI-RADS 4A Breast Nodules Using a Convolutional Neural Network

CONCLUSION: DL was developed to discriminate US BI-RADS 4A lesions with a higher diagnostic power and more clinical net benefit than CE. Using DL may guide clinicians to make precise clinical decisions and avoid overtreatment of benign lesions.PMID:38494415 | DOI:10.1016/j.clbc.2024.02.003

Source: Clinical Genitourinary Cancer - March 17, 2024 Category: Cancer & Oncology Authors: Mei Yi Yue Lin Zehui Lin Ziting Xu Lian Li Ruobing Huang Weijun Huang Nannan Wang Yanling Zuo Nuo Li Dong Ni Yanyan Zhang Yingjia Li Source Type: research